Literature DB >> 23701512

Blood plasma reference material: a global resource for proteomic research.

Johan Malm1, Pia Danmyr, Rolf Nilsson, Roger Appelqvist, Akos Végvári, György Marko-Varga.   

Abstract

There is an ever-increasing awareness and interest within the clinical research field, creating a large demand for blood fraction samples as well as other clinical samples. The translational research area is another field that is demanding for blood samples, used widely in proteomics, genomics, as well as metabolomics. Blood samples are globally the most common biological samples that are used in a broad variety of applications in life science. We hereby introduce a new reference blood plasma standard (heparin) that is aimed as a global resource for the proteomics community. We have developed these reference plasma standards by defining the Control group as those with C-reactive protein levels <3 mg/L and a Disease group with C-reactive protein ranges >30 mg/L. In these references we have used both newborn children 1-2 weeks, as well as youngsters 15-30 years, and middle aged 30-50 years, and elderly patients at the ages of 65+. In total, there were 80 patients in each group in the reference plasma pools. We provide data on the developments and characteristics of the reference blood plasma standards, as well as what is used by the team members at the respective laboratories. The standards have been evaluated by pilot sample processing in biobanking operations and are currently a resource that allows the Proteomic society to perform quantitative proteomic studies. By the use of high quality reference plasma samples, global initiatives, such as the Chromosome Human Proteome Project (C-HPP), will benefit as one scientific program when the entire human proteome is mapped and linked to human diseases. The plasma reference standards are a global resource and can be accessed upon request.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23701512     DOI: 10.1021/pr400131r

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  5 in total

1.  Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies.

Authors:  Johan Malm; Henrik Lindberg; David Erlinge; Roger Appelqvist; Maria Yakovleva; Charlotte Welinder; Erik Steinfelder; Thomas E Fehniger; György Marko-Varga
Journal:  Clin Transl Med       Date:  2015-08-14

2.  Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease.

Authors:  Magda Oliveira Seixas Carvalho; André Luís Carvalho Santos Souza; Mauricio Batista Carvalho; Ana Paula Almeida Souza Pacheco; Larissa Carneiro Rocha; Valma Maria Lopes do Nascimento; Camylla Vilas Boas Figueiredo; Caroline Conceição Guarda; Rayra Pereira Santiago; Adekunle Adekile; Marilda de Souza Goncalves
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

3.  Clinical protein science in translational medicine targeting malignant melanoma.

Authors:  Jeovanis Gil; Lazaro Hiram Betancourt; Indira Pla; Aniel Sanchez; Roger Appelqvist; Tasso Miliotis; Magdalena Kuras; Henriette Oskolas; Yonghyo Kim; Zsolt Horvath; Jonatan Eriksson; Ethan Berge; Elisabeth Burestedt; Göran Jönsson; Bo Baldetorp; Christian Ingvar; Håkan Olsson; Lotta Lundgren; Peter Horvatovich; Jimmy Rodriguez Murillo; Yutaka Sugihara; Charlotte Welinder; Elisabet Wieslander; Boram Lee; Henrik Lindberg; Krzysztof Pawłowski; Ho Jeong Kwon; Viktoria Doma; Jozsef Timar; Sarolta Karpati; A Marcell Szasz; István Balázs Németh; Toshihide Nishimura; Garry Corthals; Melinda Rezeli; Beatrice Knudsen; Johan Malm; György Marko-Varga
Journal:  Cell Biol Toxicol       Date:  2019-03-21       Impact factor: 6.691

4.  Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study.

Authors:  Mikael Truedsson; Johan Malm; K Barbara Sahlin; May Bugge; Elisabet Wieslander; Magnus Dahlbäck; Roger Appelqvist; Thomas E Fehniger; György Marko-Varga
Journal:  Clin Transl Med       Date:  2016-03-07

5.  Merging clinical chemistry biomarker data with a COPD database - building a clinical infrastructure for proteomic studies.

Authors:  Jonatan Eriksson; Simone Andersson; Roger Appelqvist; Elisabet Wieslander; Mikael Truedsson; May Bugge; Johan Malm; Magnus Dahlbäck; Bo Andersson; Thomas E Fehniger; György Marko-Varga
Journal:  Proteome Sci       Date:  2017-04-21       Impact factor: 2.480

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.